Moreover, in that model, heavy proteinuria, podocyte injury, and glomerulosclerosis were almost completely prevented by an MR antagonist, eplerenone, along with a partial but significant reduction in systolic blood pressure. The gene discussed is NR3C2; the disease is glomerulosclerosis.